Immune–pigment dynamics in uveal melanoma
Cell Signaling · 30.04.2026 · 4 (1) · 44
DOI: 10.46439/signaling.4.095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Signaling, online erschienen am 30.04.2026. Verfasst von Jayanti Jha und 11 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
In uveal melanoma (UM), increased M2 macrophage infiltration and high tumor pigmentation are well-established adverse prognostic features, yet their biological interplay remains underexplored. Emerging evidence indicates that these characteristics frequently coexist in genetically high-risk tumors, particularly those with monosomy 3 and BAP1 loss. This commentary proposes that highly pigmented tumor cells and M2-polarised macrophages form an integrated, immunosuppressive tumor ecosystem that promotes immune tolerance and tumor progression. Recognizing immune–pigment coexistence provides a refined framework for prognostic assessment and highlights microenvironmental interactions as potential targets for future therapeutic strategies in UM. Understanding these dynamics may improve risk stratification and development of targeted therapies.
Zitieren
APA
Jha, J., Singh, M. K., Singh, L., Pushker, N., Kakkar, A., Meel, R., Lomi, N., Bakhshi, S., Nag, T. C., Panwar, C., Sen, S., & Kashyap, S. (2026). Immune–pigment dynamics in uveal melanoma. Cell Signaling, 4(1), 44. https://doi.org/10.46439/signaling.4.095
Vancouver
Jha J, Singh MK, Singh L, Pushker N, Kakkar A, Meel R, et al. Immune–pigment dynamics in uveal melanoma. Cell Signaling. 2026;4(1):44. doi:10.46439/signaling.4.095
BibTeX
@article{Jha2026,
author = {Jha, Jayanti and Singh, Mithalesh Kumar and Singh, Lata and Pushker, Neelam and Kakkar, Aanchal and Meel, Rachna and Lomi, Neiwete and Bakhshi, Sameer and Nag, Tapas Chandra and Panwar, Chanda and Sen, Seema and Kashyap, Seema},
title = {Immune–pigment dynamics in uveal melanoma},
journal = {Cell Signaling},
year = {2026},
volume = {4},
number = {1},
pages = {44},
doi = {10.46439/signaling.4.095}
}
EUVIMED